Psoriasis Blog

The U.S. Food and Drug Administration (FDA) approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis. About 6 million people in the United States have plaque psoriasis. “This Stelara approval provides an alternative treatment for people with plaque psoriasis, which can cause significant physical discomfort from pain [...]

Read the full story